Genomictree Inc. (228760) - Total Liabilities

Latest as of December 2025: ₩5.45 Billion KRW ≈ $3.69 Million USD

Based on the latest financial reports, Genomictree Inc. (228760) has total liabilities worth ₩5.45 Billion KRW (≈ $3.69 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Genomictree Inc. (228760) cash flow conversion to assess how effectively this company generates cash.

Genomictree Inc. - Total Liabilities Trend (2020–2025)

This chart illustrates how Genomictree Inc.'s total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Genomictree Inc. to evaluate the company's liquid asset resilience ratio.

Genomictree Inc. Competitors by Total Liabilities

The table below lists competitors of Genomictree Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
Agung Podomoro Land Tbk JK:APLN	Indonesia	Rp12.08 Trillion
Siyaram Silk Mills Limited NSE:SIYSIL	India	Rs8.27 Billion
Erdene Resource Development Corp TO:ERD	Canada	CA$1.55 Million
Chia Hsin Cement Corp TW:1103	Taiwan	NT$14.45 Billion
Automatic Bank Services Ltd TA:SHVA	Israel	ILA48.05 Million
Arlandastad Group AB ST:AGROUP	Sweden	Skr3.13 Billion
Compagnie d Entreprises CFE SA BR:CFEB	Belgium	€803.77 Million

Liability Composition Analysis (2020–2025)

This chart breaks down Genomictree Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 228760 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	17.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genomictree Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genomictree Inc. (2020–2025)

The table below shows the annual total liabilities of Genomictree Inc. from 2020 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩5.45 Billion ≈ $3.69 Million	-14.22%
2024-12-31	₩6.36 Billion ≈ $4.31 Million	-18.64%
2023-12-31	₩7.81 Billion ≈ $5.29 Million	-86.01%
2022-12-31	₩55.86 Billion ≈ $37.85 Million	-9.98%
2021-12-31	₩62.05 Billion ≈ $42.05 Million	+174.07%
2020-12-31	₩22.64 Billion ≈ $15.34 Million	--

About Genomictree Inc.

KQ:228760 Korea Biotechnology

Market Cap

$279.13 Million

₩411.89 Billion KRW

Market Cap Rank

#15256 Global

#569 in Korea

Share Price

₩17150.00

Change (1 day)

-3.11%

52-Week Range

₩11850.00 - ₩32000.00

All Time High

₩38550.00